Investment objective & strategy
As of Jan. 28, 2026 · prospectusObjective. The FundX Future Fund Opportunities ETF (the Fund or the Future ETF) seeks to provide capital appreciation.
Strategy. The Fund is an actively managed ETF that, under normal market conditions, will invest in equity securities of companies that the Advisor and Sub-Advisor (the Advisors) believe to be best positioned to take advantage of long-term megatrends. Long-term megatrends are driven by changes in technology, consumer preferences, demographics, and environmental sustainability, which can lead to significant increases in their markets, earnings trajectories, and market capitalizations. As part of the investment process, the Advisors seek to identify potential opportunities created by changes in technology, consumer preferences, demographics, regulatory, environmental and supply/demand dynamics that unfold over long periods of time (secular trends) and the companies that can significantly benefit and profit from such trends. Through a proprietary research driven process, the Advisors … The Fund is an actively managed ETF that, under normal market conditions, will invest in equity securities of companies that the Advisor and Sub-Advisor (the Advisors) believe to be best positioned to take advantage of long-term megatrends. Long-term megatrends are driven by changes in technology, consumer preferences, demographics, and environmental sustainability, which can lead to significant increases in their markets, earnings trajectories, and market capitalizations. As part of the investment process, the Advisors seek to identify potential opportunities created by changes in technology, consumer preferences, demographics, regulatory, environmental and supply/demand dynamics that unfold over long periods of time (secular trends) and the companies that can significantly benefit and profit from such trends. Through a proprietary research driven process, the Advisors analyze companies across sectors and secular trends or themes (e.g., green energy, online shopping or cybersecurity) to try to identify for investment those companies it believes to be thematic winners (companies that the Advisors believe can benefit from positive secular trends or themes) with reasonable valuations. The Advisors will sell a security when it believes the outlook for outperformance has deteriorated. The Fund will invest its assets in U.S. exchange-listed equity securities and American Depositary Receipts (ADRs) of small to mid-capitalization companies (companies with market capitalizations less than $25 billion). The equity securities in which the Fund may invest include common stock, preferred stock, exchange traded funds and convertible securities. ADRs are U.S. issued and denominated securities or pools of securities of a foreign issuer. The Fund may invest in foreign securities listed on foreign exchanges. The Funds investments in foreign equity securities will be in both developed and emerging markets. The Advisors anticipate using a long-term approach to investing that typically results in low to moderate portfolio turnover. The Advisors, however, may increase portfolio turnover, depending upon market conditions. The Fund may lend portfolio securities to brokers, dealers, and other financial organizations that meet capital and other credit requirements or other criteria established by the Board of Trustees. Loans, if and when made, may not exceed 33 1/3% of the total assets of the Fund (including the collateral for the loan). Cash collateral may be invested in short-term investments, including repurchase agreements and money market funds that meet the requirements of Rule 2a-7 of the Investment Company Act of 1940 (the 1940 Act). Repurchase transactions will be fully collateralized at all times with cash and/or short-term debt obligations. The Fund may increase the amount of income received by payments from the borrow when lending securities.
Top holdings
As of March 31, 2026 · N-PORT| Security | Ticker | Value | % of fund |
|---|---|---|---|
| FRST AM-GV OB-X | TMPXX | $11.73M | 5.97% |
| TECHNIPFMC PLC | — | $6.40M | 3.26% |
| MILLICOM INTL CELL SA | TIGO | $6.02M | 3.06% |
| GLOBUS MEDICAL INC | — | $4.49M | 2.29% |
| IONIS PHARMACEUTICALS INC | — | $4.41M | 2.24% |
| GUARDANT HEALTH INC | — | $4.29M | 2.18% |
| BWX TECHNOLOGIES INC | — | $4.01M | 2.04% |
| HALOZYME THERAPEUTICS INC | — | $3.85M | 1.96% |
| ADVANCED DRAINAGE SYSTEMS INC | — | $3.75M | 1.91% |
| ONTO INNOVATION INC | — | $3.73M | 1.90% |
Portfolio moves
Dec 31, 2025 → Mar 31, 2026How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.
Similar funds
Funds whose portfolios most overlap this one, by weight| Fund | Overlap | Net exp. |
|---|---|---|
| Victory RS Select Growth Fund · RSDGX, RSGFX, RSSYX, RSSRX | 22% | 1.06% |
| S&P MidCap 400 Pure Growth Fund · RYBHX, RYMGX, RYCKX | 21% | 1.53% |
| S&P MidCap 400 Pure Growth Fund | 21% | 1.64% |
Footnotes
- Expense ratio as of January 28, 2026, from the fund's prospectus.
- Net assets and holdings count as of March 31, 2026, from the fund's N-PORT filing.
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.